{
    "Trade/Device Name(s)": [
        "Immunoscan CCPlus"
    ],
    "Submitter Information": "Euro-Diagnostica AB",
    "510(k) Number": "K091657",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052133"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NHX"
    ],
    "Summary Letter Date": "September 28, 2009",
    "Summary Letter Received Date": "October 1, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.5775"
    ],
    "Regulation Name(s)": [
        "Rheumatoid factor immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgG antibodies to Cyclic Citrullinated Peptides (CCP)",
        "Anti-CCP"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)"
    ],
    "Methodologies": [
        "Qualitative determination",
        "Semi-quantitative determination"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Immunoscan CCPlus ELISA kit for qualitative and semi-quantitative detection of anti-CCP IgG antibodies in human serum as an aid in diagnosing rheumatoid arthritis",
    "Indications for Use Summary": "Aid in diagnosis of rheumatoid arthritis by qualitative and semi-quantitative determination of IgG antibodies to cyclic citrullinated peptides in human serum using ELISA, for use by trained laboratory professionals",
    "fda_folder": "Immunology"
}